We are live on ! Find out more
HM

HealthCor Management Portfolio holdings

AUM $109M
1-Year Est. Return 10.64%
This Fund
S&P 500
This Quarter Est. Return
+8.55%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$2.5B
AUM Growth
+$112M
Cap. Flow
+$22.9M
Cap. Flow %
0.92%
Top 10 Hldgs %
54.31%
Holding
65
New
15
Increased
17
Reduced
8
Closed
25

Top Buys

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$149M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$95.6M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$92.9M
4
UNH icon
UnitedHealth
UNH
+$86.5M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$81.1M

Top Sells

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$145M
2
LH icon
Labcorp
LH
+$92M
3
CI icon
Cigna
CI
+$88.6M
4
EHC icon
Encompass Health
EHC
+$77.2M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$74.8M

Sector Composition

Rank Sector Weight
1 Healthcare 98.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LEGN icon
51
Legend Biotech
LEGN
$4.01B
– –
-75,000
Closed -$3.19M
LH icon
52
Labcorp
LH
$25.9B
– –
-644,868
Closed -$92M
LIVN icon
53
LivaNova
LIVN
$4.2B
– –
-1,445,500
Closed -$69.6M
MRK icon
54
Merck
MRK
$318B
– –
-180,581
Closed -$13.3M
PCRX icon
55
Pacira BioSciences
PCRX
$997M
– –
-405,040
Closed -$21.3M
RNAM
56
DELISTED
Avidity Biosciences
RNAM
– –
-50,000
Closed -$1.41M
TMO icon
57
Thermo Fisher Scientific
TMO
$220B
– –
-152,180
Closed -$55.1M
FUSN
58
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
– –
-150,000
Closed -$2.62M
IMGN
59
DELISTED
Immunogen Inc
IMGN
– –
-1,200,000
Closed -$5.52M
SDC
60
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
– –
-700,000
Closed -$5.53M
NUVA
61
DELISTED
NuVasive, Inc.
NUVA
– –
-969,580
Closed -$54M
AKUS
62
DELISTED
Akouos Inc
AKUS
– –
-100,000
Closed -$2.25M
SRGA
63
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
– –
-71,955
Closed -$6.86M
ALXN
64
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-666,510
Closed -$74.8M
BMY.RT
65
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
– –
-1,115,000
Closed -$3.99M
1 2
3

Similar funds

IA
Integrity Advisory Overland Park, Kansas $109M AUM 15.71% 1-Year Est. Return
EPC
Emerson Point Capital Larchmont, New York $108M AUM 19.03% 1-Year Est. Return
TCMV
Technology Crossover Management VII Menlo Park, California $107M AUM 51.05% 1-Year Est. Return
SI
Salesforce Inc San Francisco, California $114M AUM 53.18% 1-Year Est. Return
HCWM
Harrison & Co Wealth Management Roanoke, Virginia $103M AUM 9.82% 1-Year Est. Return
PC
Phoenician Capital New York $117M AUM 9.46% 1-Year Est. Return
RF
Resolute Financial Newburyport, Massachusetts $118M AUM 11.75% 1-Year Est. Return
AWM
Align Wealth Management Oklahoma City, Oklahoma $118M AUM

HealthCor Management's Q3 2020 Portfolio in Review

As of Q3 2020, HealthCor Management held 65 positions worth $2.5B, up 4.7% from $2.39B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

HealthCor Management's Q3 2020 filing shows 15 new, 17 increased, 8 reduced and 25 closed positions. Its largest new stake was Cooper Companies: 966,160 shares worth $81.4M. The largest sale was Becton Dickinson, an estimated $145M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 100% a quarter earlier.

  • HealthCor Management's largest Q3 2020 buy was Cooper Companies: 966,160 shares worth $81.4M.
  • HealthCor Management added most to Zimmer Biomet in Q3 2020, an estimated $149M increase.
  • HealthCor Management's biggest Q3 2020 reduction was Bristol-Myers Squibb, cutting an estimated $56.4M.
  • HealthCor Management fully exited Becton Dickinson in Q3 2020, selling an estimated $145M.
  • HealthCor Management's ten largest holdings make up 54% of its $2.5B portfolio in Q3 2020.
  • HealthCor Management opened 15 new positions and closed 25 in Q3 2020.
  • HealthCor Management's portfolio value rose 4.7% quarter-over-quarter to $2.5B.

Based on HealthCor Management's 13F filing for Q3 2020, filed 16 Nov 2020.